Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited has announced the cessation of a tranche of options due to an agreement with the option holders. The options, identified by the ASX security code AGNAE with an expiry date of September 30, 2024, and an exercise price of $0.30, were canceled on August 8, 2024. This event could indicate strategic financial movements within the company, potentially impacting its stock value and investor decisions.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
